Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit?
about
Preoperative selection of patients with colorectal cancer liver metastasis for hepatic resectionEffects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumorsNew Perspectives in the Treatment of Colorectal Metastases'Staged' liver resection in synchronous and metachronous colorectal hepatic metastases: differences in clinicopathological features and outcome.Stereotactic body radiation therapy using the CyberKnife(®) system for patients with liver metastasesThe surgical treatment of patients with colorectal cancer and liver metastases in the setting of the "liver first" approach.Racial disparity in surgical mortality after major hepatectomy.Prognostic significance of C-reactive protein polymorphism and KRAS/BRAF in synchronous liver metastasis from colorectal cancer.PAMAM-camptothecin conjugate inhibits proliferation and induces nuclear fragmentation in colorectal carcinoma cells.Sinusoidal obstruction syndrome (hepatic veno-occlusive disease)Percutaneous Cryoablation of Metastatic Lesions from Colorectal Cancer: Efficacy and Feasibility with Survival and Cost-Effectiveness Observations.Value of diffusion weighted MR imaging as an early surrogate parameter for evaluation of tumor response to high-dose-rate brachytherapy of colorectal liver metastases.The role of peri-operative treatment in resectable liver metastases of colorectal cancer.Survival in patients with synchronous liver metastases in central and northern Denmark, 1998 to 2009Fatty acid synthase-positive hepatocytes and subsequent steatosis in rat livers by irinotecan.Cancerous inhibitor of protein phosphatase 2A (CIP2A) is an independent prognostic marker in wild-type KRAS metastatic colorectal cancer after colorectal liver metastasectomyVariable Pringle Maneuvers and Effect on Intestinal Epithelium in Rats. A Pilot Experimental Study in Rats.Histologic evaluation of intrahepatic micrometastases in patients treated with or without neoadjuvant chemotherapy for colorectal carcinoma liver metastasis.Metastatic Tissue Proteomic Profiling Predicts 5-Year Outcomes in Patients with Colorectal Liver Metastases.Integrating Chemotherapy into the Management of Oligometastatic Colorectal Cancer: Evidence-Based Approach Using Clinical Trial FindingsKinetics of liver function tests after a hepatectomy for colorectal liver metastases predict post-operative liver failure as defined by the International Study Group for Liver Surgery.Hydroxylated collagen peptide in urine as biomarker for detecting colorectal liver metastasesHepatic colorectal metastases involving infra-hepatic inferior vena cava in high risk patients for extended resection: an alternative method for achieving radical resection in patient with borderline liver remnant.A systematic review of two-stage hepatectomy in patients with initially unresectable colorectal liver metastasesOptimizing the approach to patients with potentially resectable liver metastases from colorectal cancer.PRL-3 is essentially overexpressed in primary colorectal tumours and associates with tumour aggressiveness.Stereotactic body radiotherapy for patients with oligometastases from colorectal cancer: risk-adapted dose prescription with a maximum dose of 83-100 Gy in five fractions.Prognostic factors and time-related changes influence results of colorectal liver metastases surgical treatment: a single-center analysis.Yttrium-90 radioembolization as salvage therapy for colorectal cancer with liver metastases.Treatment of Liver Metastases From Colorectal Cancer: Medico-Surgical StrategiesRepeat liver resection for recurrent colorectal metastases: a single-centre, 13-year experience.Chromothripsis and progression-free survival in metastatic colorectal cancer.Role of stereotactic body radiotherapy for oligometastasis from colorectal cancer.Colorectal cancer: current care, future innovations and economic considerations.Role of surgery in colorectal liver metastases: too early or too late?Advances in therapeutics for liver metastasis from colorectal cancer.Surgical treatment of hepatic metastases from colorectal cancer.Treatment recommendations for metastatic colorectal cancer.A systematic review of clinical response and survival outcomes of downsizing systemic chemotherapy and rescue liver surgery in patients with initially unresectable colorectal liver metastases.Liver metastases from colorectal cancer: how to best complement medical treatment with surgical approaches.
P2860
Q26774687-01FE0985-7960-4289-AC3C-D8DFE32AA0A6Q26799046-1BFA7FFC-D575-4B46-9A10-89D6ADC0F360Q28073788-8E2C201D-D005-49DD-9E58-0F7A0E38BE43Q33515915-1A8CA857-A060-46C5-945D-516103CEE05FQ33769424-9EEDBC42-DA24-412C-AAA0-D2FDF3B6F7D5Q34395932-C2D5CD50-ED05-4923-B179-30EA49C28A47Q34443391-46057446-4018-499B-BE78-3CFDA3081028Q34766068-5409EA02-CCF8-4720-8D92-8E8F799EBCB2Q34974038-8CAE9885-BCD3-4B28-BF64-5FA694280956Q34983459-72A971AE-9EF3-4A4B-AE12-33FD17F94BA9Q34993548-BDDFE7E2-ADFD-4BB1-9CD7-73AE1C595571Q35035353-D4E0192F-1A10-4403-9CAE-F5A34546C751Q35076305-2CE16C27-BC42-4F93-87CE-BFE6315D543BQ35131237-FD7035D4-78C4-4C2E-B857-1850990941CAQ35343063-872920B7-396F-4797-81FD-A51A0D1AEC16Q35503680-7B357BCD-00E4-461F-A279-526654A9B182Q35819079-07D1712D-6C3F-41E3-AE46-99A6CEE993A5Q36003241-060FF1F7-E49F-4FD2-A9B7-A199D884BD64Q36165524-225052D6-2681-4B64-AD26-1F31DB9F99FAQ36396031-9D265F14-FA2E-48D1-9940-AD37BE343327Q36786141-A6FC7130-7959-4D9C-B7D6-17978471DD42Q36878725-70F08F1B-9760-4E7A-962B-0893B68EDD0DQ36946329-BDBB839C-34D4-4D4D-B0FD-13C4A1C1C64BQ36953786-509443D6-1212-493C-B242-5553B158A259Q36968386-0674082A-F62F-4DC4-A5DE-F435D939D9C0Q36977592-42D1A40D-354B-40C3-AAB8-633E2DE7C785Q37152196-C1F37D15-F54A-4CF6-A6F8-1B3676E125D1Q37214575-8E1093D9-6373-4357-A259-A32CA351B5B8Q37339616-8CE4A8CA-7DB2-4871-88B8-9446A45640F0Q37477749-64B67E2A-4F6D-4016-B585-E719F16926ECQ37577597-42182791-B4D9-496F-9772-B897184B6D20Q37701746-3A199493-9279-4DFC-8431-C73BCFA6FE0CQ37708013-AE206788-4260-4C29-87CB-41AE0A436ECFQ37763182-00E6A7C4-81C8-4890-95CF-6E9D663B1713Q37774980-AFDF4957-665F-4E78-9264-40767188A1C7Q37821285-1E9C8EC7-8FBA-4E86-93D7-73154E86B6E4Q37832394-AAAAA082-0BDE-4714-8C18-7D0FA6F083D7Q37855303-531042C8-3263-4869-9A68-A74FE4D80376Q37933143-287ECB19-312D-422E-9962-736D0AECB825Q37951604-8CB6191C-F538-4EA6-800C-6D1987951F82
P2860
Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit?
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Extending the frontiers of sur ...... metastases: is there a limit?
@ast
Extending the frontiers of sur ...... metastases: is there a limit?
@en
Extending the frontiers of sur ...... metastases: is there a limit?
@nl
type
label
Extending the frontiers of sur ...... metastases: is there a limit?
@ast
Extending the frontiers of sur ...... metastases: is there a limit?
@en
Extending the frontiers of sur ...... metastases: is there a limit?
@nl
prefLabel
Extending the frontiers of sur ...... metastases: is there a limit?
@ast
Extending the frontiers of sur ...... metastases: is there a limit?
@en
Extending the frontiers of sur ...... metastases: is there a limit?
@nl
P2093
P356
P1476
Extending the frontiers of sur ...... metastases: is there a limit?
@en
P2093
Jacques Belghiti
Nicholas J Petrelli
Vijay P Khatri
P304
P356
10.1200/JCO.2004.00.6155
P407
P577
2005-10-17T00:00:00Z